Dr. Chandra is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
675 N Saint Clair St
Chicago, IL 60611Phone+1 312-695-5378Fax+1 312-695-0188
Education & Training
NYU Grossman School of MedicineFellowship, Hematology and Medical Oncology, 2011 - 2014
Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Internal Medicine, 2008 - 2011
Michigan State University College of Human MedicineClass of 2008
Certifications & Licensure
IL State Medical License 2014 - 2026
NY State Medical License 2011 - 2016
OH State Medical License 2008 - 2011- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
- Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer Start of enrollment: 2019 May 17
- Study of Ruxolitinib in Solid Organ Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2021 Jul 08
Publications & Presentations
PubMed
- 12 citationsEndocrine side effects of immune checkpoint inhibitors.Zulma Cardona, Jeffrey A Sosman, Sunandana Chandra, Wenyu Huang
Frontiers in Endocrinology. 2023-01-01 - 1567 citationsFatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysisDaniel Y. Wang, Joe-Elie Salem, Justine V. Cohen, Sunandana Chandra, Christian Menzer
JAMA Oncology. 2018-12-01 - 118 citationsA case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitisDouglas B. Johnson, Wyatt J. McDonnell, Paula I. Gonzalez-Ericsson, Rami N. Al-Rohil, Bret C. Mobley
Nature Medicine. 2019-07-22
Press Mentions
Scientists Discover Potential Biomarker in Rare Skin CancerJuly 26th, 2024- The Importance of Having Difficult Conversations with PatientsDecember 2nd, 2022
- mRNA Vaccines Get Ready for Their Next Act: Fighting CancerSeptember 21st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
